Sunshine Biopharma (SBFM) Total Non-Current Liabilities: 2018-2025
Historic Total Non-Current Liabilities for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to $636,708.
- Sunshine Biopharma's Total Non-Current Liabilities rose 30.20% to $636,708 in Q3 2025 from the same period last year, while for Sep 2025 it was $636,708, marking a year-over-year increase of 30.20%. This contributed to the annual value of $744,724 for FY2024, which is 26.70% up from last year.
- According to the latest figures from Q3 2025, Sunshine Biopharma's Total Non-Current Liabilities is $636,708, which was down 9.88% from $706,530 recorded in Q2 2025.
- Sunshine Biopharma's 5-year Total Non-Current Liabilities high stood at $744,724 for Q4 2024, and its period low was $489,027 during Q3 2024.
- For the 3-year period, Sunshine Biopharma's Total Non-Current Liabilities averaged around $621,732, with its median value being $636,708 (2025).
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first fell by 20.04% in 2024, then soared by 38.09% in 2025.
- Over the past 4 years, Sunshine Biopharma's Total Non-Current Liabilities (Quarterly) stood at $685,264 in 2022, then dropped by 14.23% to $587,764 in 2023, then climbed by 26.70% to $744,724 in 2024, then skyrocketed by 30.20% to $636,708 in 2025.
- Its Total Non-Current Liabilities stands at $636,708 for Q3 2025, versus $706,530 for Q2 2025 and $722,199 for Q1 2025.